$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000117992915000109 Filed on July 30, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$3.525B	$2.312B
YoY Change	52.46%	43.98%
Cost Of Revenue	$2.962B	$1.971B
YoY Change	50.27%	47.78%
Gross Profit	$389.0M	$340.6M
YoY Change	14.21%	25.31%
Gross Profit Margin	11.04%	14.73%
Selling, General & Admin	$421.8M	$285.3M
YoY Change	47.84%	36.9%
% of Gross Profit	108.43%	83.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$29.50M	$32.70M
YoY Change	-9.79%	47.91%
% of Gross Profit	7.58%	9.6%
Operating Expenses	$446.9M	$308.2M
YoY Change	45.0%	36.73%
Operating Profit	$116.0M	$32.00M
YoY Change	262.5%	-31.1%
Interest Expense	$15.00M	$13.99M
YoY Change	7.2%	19.94%
% of Operating Profit	12.93%	43.73%
Other Income/Expense, Net	$15.00M	-$13.98M
YoY Change	-207.27%	-7.81%
Pretax Income	$101.0M	$18.44M
YoY Change	447.63%	-41.03%
Income Tax	$62.00M	$10.70M
% Of Pretax Income	61.39%	58.03%
Net Earnings	$39.00M	$8.000M
YoY Change	387.5%	-67.44%
Net Earnings / Revenue	1.11%	0.35%
Basic Earnings Per Share	$0.78	$0.17
Diluted Earnings Per Share	$0.72	$0.16
COMMON SHARES
Basic Shares Outstanding	50.00M shares	46.28M shares
Diluted Shares Outstanding	54.00M shares	48.00M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.481B	$1.768B
YoY Change	96.84%	21.01%
Cash & Equivalents	$2.014B	$1.027B
Short-Term Investments	$1.467B	$740.9M
Other Short-Term Assets	$148.6M	$93.86M
YoY Change	58.33%	96.29%
Inventory
Prepaid Expenses
Receivables	$631.1M	$473.5M
Other Receivables	$0.00	$16.70M
Total Short-Term Assets	$4.806B	$2.372B
YoY Change	102.64%	35.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$363.2M	$317.6M
YoY Change	14.36%	27.41%
Goodwill	$272.0M	$230.7M
YoY Change	17.9%	50.66%
Intangibles
YoY Change
Long-Term Investments		$11.00M
YoY Change		-12.0%
Other Assets	$37.81M	$45.65M
YoY Change	-17.17%	27.62%
Total Long-Term Assets	$929.9M	$1.080B
YoY Change	-13.91%	29.35%
TOTAL ASSETS
Total Short-Term Assets	$4.806B	$2.372B
Total Long-Term Assets	$929.9M	$1.080B
Total Assets	$5.736B	$3.452B
YoY Change	66.17%	33.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$399.2M	$475.4M
YoY Change	-16.03%	163.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$445.7M	$185.5M
YoY Change	140.32%
Total Short-Term Liabilities	$3.739B	$1.631B
YoY Change	129.23%	130.63%
LONG-TERM LIABILITIES
Long-Term Debt	$474.3M	$625.3M
YoY Change	-24.15%	-17.89%
Other Long-Term Liabilities	$31.10M	$28.72M
YoY Change	8.27%	19.95%
Total Long-Term Liabilities	$31.10M	$28.72M
YoY Change	8.27%	19.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.739B	$1.631B
Total Long-Term Liabilities	$31.10M	$28.72M
Total Liabilities	$4.273B	$2.535B
YoY Change	68.56%	48.81%
SHAREHOLDERS EQUITY
Retained Earnings	$682.4M	$565.4M
YoY Change	20.69%	1.94%
Common Stock	$782.4M	$351.5M
YoY Change	122.57%	8.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.463B	$917.1M
YoY Change
Total Liabilities & Shareholders Equity	$5.736B	$3.452B
YoY Change	66.17%	33.8%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$39.00M	$8.000M
YoY Change	387.5%	-67.44%
Depreciation, Depletion And Amortization	$29.50M	$32.70M
YoY Change	-9.79%	47.91%
Cash From Operating Activities	$94.10M	$24.60M
YoY Change	282.52%	-118.66%
INVESTING ACTIVITIES
Capital Expenditures	-$40.90M	-$19.90M
YoY Change	105.53%	-17.08%
Acquisitions
YoY Change
Other Investing Activities	-$288.2M	-$55.00M
YoY Change	424.0%	-85.77%
Cash From Investing Activities	-$329.0M	-$74.80M
YoY Change	339.84%	-81.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$373.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	378.9M	-5.800M
YoY Change	-6632.76%	-105.01%
NET CHANGE
Cash From Operating Activities	94.10M	24.60M
Cash From Investing Activities	-329.0M	-74.80M
Cash From Financing Activities	378.9M	-5.800M
Net Change In Cash	144.0M	-56.00M
YoY Change	-357.14%	-86.88%
FREE CASH FLOW
Cash From Operating Activities	$94.10M	$24.60M
Capital Expenditures	-$40.90M	-$19.90M
Free Cash Flow	$135.0M	$44.50M
YoY Change	203.37%	-141.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	14685000	USD
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	dei	Trading Symbol TradingSymbol	moh
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	13455000	USD
CY2014Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	7600000	USD
CY2015Q2	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	30800000	USD
CY2014Q4	moh	Capitation Claims Payable CapitationClaimsPayable	28150000	USD
CY2015Q2	moh	Capitation Claims Payable CapitationClaimsPayable	30673000	USD
	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2015Q2	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2014Q2	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	21945000	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	44135000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56056000	shares
CY2015Q2	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	40652000	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	81430000	USD
CY2014Q2	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	19662000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	38358000	USD
CY2015Q2	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	73890000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	121838000	USD
CY2014Q2	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	70120000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	121813000	USD
CY2015Q2	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	94609000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	189956000	USD
	moh	Health Care Organization Prior Year Claimsand Claims Adjustment Medical Provision Expense HealthCareOrganizationPriorYearClaimsandClaimsAdjustmentMedicalProvisionExpense	-22000000	USD
	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	119872000	USD
	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	297741000	USD
CY2014Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	160710000	USD
CY2015Q2	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	161323000	USD
	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
CY2014Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	119300000	USD
CY2015Q2	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	134200000	USD
CY2014	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-31973000	USD
	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	14826000	USD
CY2014Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	527193000	USD
CY2015Q2	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	824934000	USD
CY2014Q4	moh	Other Claims Payable OtherClaimsPayable	230531000	USD
CY2015Q2	moh	Other Claims Payable OtherClaimsPayable	241883000	USD
CY2014Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	71412000	USD
CY2015Q2	moh	Pharmacy Claims Payable PharmacyClaimsPayable	80902000	USD
CY2014	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.069
	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.115
CY2014	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.006
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.014
CY2014	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.005
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.012
CY2014Q2	moh	Premium Tax Expenses PremiumTaxExpenses	70120000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	121813000	USD
CY2015Q2	moh	Premium Tax Expenses PremiumTaxExpenses	94609000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	189956000	USD
	moh	Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation	13200000	USD
CY2014Q2	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	0	shares
	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	0	shares
CY2015Q2	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	1365000	shares
	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	687000	shares
CY2014Q2	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	16000	shares
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	279000	shares
CY2015Q2	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	25000	shares
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	203000	shares
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241654000	USD
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	399186000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8987000	USD
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10396000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1019000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1830000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	396059000	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	782433000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4860000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10456000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3566000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9241000	USD
CY2014Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6414000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12728000	USD
CY2015Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7086000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14072000	USD
CY2014Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	859000000	USD
CY2015Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1005000000	USD
CY2014Q4	us-gaap	Assets Assets	4477215000	USD
CY2015Q2	us-gaap	Assets Assets	5736159000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	3245397000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	4806227000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1025951000	USD
CY2015Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1471892000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1024309000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1468987000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	395000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	635000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2037000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3540000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	598000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	544000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1439000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2996000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	539475000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	801780000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	47576000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	90087000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	32848000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	32576000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	740989000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	738942000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	2500000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	2365000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	695555000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	695104000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1468987000	USD
CY2014Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	416	Security
CY2015Q2	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	641	Security
CY2014Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	32	Security
CY2015Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	56	Security
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1027351000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539063000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2013882000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	91456000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	474819000	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49727000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56050000	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2015Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	56000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8233000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13435000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36816000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66285000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2015Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	147454000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	12447000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	704097000	USD
CY2015Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	272930000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	2279612000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4324588000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	3409262000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6498155000	USD
CY2014Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	53675000	USD
CY2015Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	65410000	USD
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	704097000	USD
CY2015Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	718169000	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	133382000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	196076000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	57723000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	39532000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	37480000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	24271000	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	29174000	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22902000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43593000	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25152000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50144000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65654000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62076000	USD
CY2014Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	USD
CY2015Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	508504000	USD
CY2014Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	329323000	USD
CY2015Q2	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	10000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	20000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2015Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	508355000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	329194000	USD
CY2015Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2014Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40241000	USD
CY2015Q2	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40016000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.36
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	82000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89273000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	80462000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	193239000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	381326000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	286496000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	542586000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	271964000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	272046000	USD
CY2014Q2	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	2938000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	6196000	USD
CY2015Q2	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	948000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	3251000	USD
CY2014Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2167142000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4107479000	USD
CY2015Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	3304372000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	6275024000	USD
CY2015Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	110956000	USD
CY2015Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	10167000	USD
CY2015Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	10164000	USD
CY2015Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	100792000	USD
CY2015Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	100792000	USD
CY2015Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	110959000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7741000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12575000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	38931000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	67072000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18443000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	28932000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	100714000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	168078000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.27
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.78
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.36
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.16
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.26
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.72
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.29
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	70000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-266000	USD
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	12000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	24000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10702000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16357000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61783000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101006000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	57625000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	157734000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	16016000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1409000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1692000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-7405000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-76271000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-138353000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	254395000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	291730000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	66887000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97027000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	174579000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	34668000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	15622000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	14202000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2628000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1773000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1363000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1147000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	682000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	341000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	361000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	527000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	319000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	426000	shares
CY2014Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1945000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3574000	USD
CY2015Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3828000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6843000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	13993000	USD
	us-gaap	Interest Expense InterestExpense	27815000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	14946000	USD
	us-gaap	Interest Expense InterestExpense	29822000	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	9714000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	19328000	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	9858000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	19616000	USD
CY2014Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3300000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6600000	USD
CY2015Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2772000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1126000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5544000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3466773000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	4273052000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4477215000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5736159000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2174773000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3738514000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1200522000	USD
CY2015Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1492252000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	7064427000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	4448820000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	449771000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	839536000	USD
CY2014Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	870429000	USD
CY2015Q2	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1138794000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8076906000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5565260000	USD
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	851551000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	341000	USD
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	445668000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	851551000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1019462000	USD
CY2015Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1466622000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41668000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	383958000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-102336000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-556849000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	235460000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	647710000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	7811000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12309000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	38943000	USD
	us-gaap	Net Income Loss NetIncomeLoss	67096000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13984000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27762000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14914000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29780000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	32427000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	56694000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	115628000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	197858000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	50884000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	148615000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44326000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37814000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	422000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1261000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2127000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-811000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	391000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1817000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3377000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-31000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	691000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1250000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-450000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33487000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31095000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	53000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	42000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1723000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	8641000	USD
CY2014	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	7514198000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	5288356000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7388000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	16853000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	50349000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8006000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	368304000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	992978000	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	37670000	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	65860000	USD
CY2014Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1934299000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3655957000	USD
CY2015Q2	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2929534000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	5565318000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	373200000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	373151000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7617000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8387000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1064000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2420000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	326648000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	541050000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	340778000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	363244000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	596456000	USD
CY2015Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	631124000	USD
CY2014Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	102479000	USD
CY2015Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	110956000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	615352000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	682448000	USD
CY2014Q2	us-gaap	Revenues Revenues	2312039000	USD
	us-gaap	Revenues Revenues	4381282000	USD
CY2015Q2	us-gaap	Revenues Revenues	3524890000	USD
	us-gaap	Revenues Revenues	6696013000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10456000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9241000	USD
CY2013Q4	us-gaap	Shares Outstanding SharesOutstanding	45871000	shares
CY2014Q1	us-gaap	Shares Outstanding SharesOutstanding	46263000	shares
CY2014Q4	us-gaap	Shares Outstanding SharesOutstanding	48578000	shares
CY2015Q1	us-gaap	Shares Outstanding SharesOutstanding	48852000	shares
CY2015Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1071000000	USD
CY2015Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	589000000	USD
	us-gaap	Stock Issued1 StockIssued1	8453000	USD
	us-gaap	Stock Issued1 StockIssued1	8921000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1010442000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	1463107000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	452700000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	7924000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8122885000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5703391000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-45979000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-138131000	USD
CY2014Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	37107000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	77764000	USD
CY2015Q2	us-gaap	Technology Services Costs TechnologyServicesCosts	32819000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	68721000	USD
CY2014Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	50232000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	103862000	USD
CY2015Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	47243000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	99101000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48003000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47824000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53871000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52008000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46279000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46150000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50242000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49468000	shares
	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,138,794</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,902</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,673</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241,883</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,492,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-15-000109-index-headers.html	Edgar Link	pending
0001179929-15-000109-index.html	Edgar Link	pending
0001179929-15-000109.txt	Edgar Link	pending
0001179929-15-000109-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
moh-06302015x10q.htm	Edgar Link	pending
moh-06302015x10qex311.htm	Edgar Link	pending
moh-06302015x10qex312.htm	Edgar Link	pending
moh-06302015x10qex321.htm	Edgar Link	pending
moh-06302015x10qex322.htm	Edgar Link	pending
moh-20150630.xml	Edgar Link	completed
moh-20150630.xsd	Edgar Link	pending
moh-20150630_cal.xml	Edgar Link	unprocessable
moh-20150630_def.xml	Edgar Link	unprocessable
moh-20150630_lab.xml	Edgar Link	unprocessable
moh-20150630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2015 Q2 Form 10-Q Financial Statement

#000117992915000109 Filed on July 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2015 Q2 Form 10-Q Financial Statement

#000117992915000109 Filed on July 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh